Morgan Stanley’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $247M | Buy |
3,918,943
+238,410
| +6% | +$16.7M | 0.01% | 893 |
|
|
2026
Q1 | $278M | Buy |
3,680,533
+308,130
| +9% | +$22M | 0.02% | 782 |
|
|
2025
Q4 | $208M | Buy |
3,372,403
+2,157
| +0.1% | +$127K | 0.01% | 924 |
|
|
2025
Q3 | $198M | Buy |
3,370,246
+526,596
| +19% | +$30.7M | 0.01% | 938 |
|
|
2025
Q2 | $166M | Buy |
2,843,650
+33,680
| +1% | +$1.9M | 0.01% | 974 |
|
|
2025
Q1 | $140M | Buy |
2,809,970
+44,488
| +2% | +$2.28M | 0.01% | 1039 |
|
|
2024
Q4 | $124M | Sell |
2,765,482
-515,615
| -16% | -$24.5M | 0.01% | 1105 |
|
|
2024
Q3 | $158M | Sell |
3,281,097
-587,909
| -15% | -$28.3M | 0.01% | 957 |
|
|
2024
Q2 | $197M | Buy |
3,869,006
+1,378,351
| +55% | +$75.5M | 0.02% | 813 |
|
|
2024
Q1 | $135M | Buy |
2,490,655
+54,232
| +2% | +$2.83M | 0.01% | 992 |
|
|
2023
Q4 | $137M | Sell |
2,436,423
-794,861
| -25% | -$44.9M | 0.01% | 966 |
|
|
2023
Q3 | $200M | Sell |
3,231,284
-221,299
| -6% | -$14M | 0.02% | 699 |
|
|
2023
Q2 | $204M | Buy |
3,452,583
+614,930
| +22% | +$39.1M | 0.02% | 709 |
|
|
2023
Q1 | $210M | Buy |
2,837,653
+129,678
| +5% | +$10M | 0.02% | 677 |
|
|
2022
Q4 | $198M | Sell |
2,707,975
-405,285
| -13% | -$32M | 0.02% | 693 |
|
|
2022
Q3 | $260M | Sell |
3,113,260
-412,047
| -12% | -$35.4M | 0.04% | 480 |
|
|
2022
Q2 | $281M | Buy |
3,525,307
+1,119,356
| +47% | +$109M | 0.04% | 472 |
|
|
2022
Q1 | $250M | Sell |
2,405,951
-87,763
| -4% | -$7.27M | 0.03% | 456 |
|
|
2021
Q4 | $188M | Buy |
2,493,714
+383,886
| +18% | +$26.9M | 0.02% | 595 |
|
|
2021
Q3 | $137M | Buy |
2,109,828
+83,379
| +4% | +$5.1M | 0.02% | 674 |
|
|
2021
Q2 | $123M | Sell |
2,026,449
-72,363
| -3% | -$4.28M | 0.02% | 743 |
|
|
2021
Q1 | $113M | Buy |
2,098,812
+324,419
| +18% | +$17.6M | 0.02% | 700 |
|
|
2020
Q4 | $85.5M | Buy |
1,774,393
+315,783
| +22% | +$14M | 0.01% | 795 |
|
|
2020
Q3 | $57.2M | Sell |
1,458,610
-312,701
| -18% | -$11.4M | 0.01% | 841 |
|
|
2020
Q2 | $56.9M | Sell |
1,771,311
-27,380
| -2% | -$953K | 0.01% | 784 |
|
|
2020
Q1 | $61M | Sell |
1,798,691
-849,447
| -32% | -$34M | 0.02% | 661 |
|
|
2019
Q4 | $127M | Buy |
2,648,138
+713,962
| +37% | +$34.5M | 0.03% | 515 |
|
|
2019
Q3 | $96.5M | Buy |
1,934,176
+504,066
| +35% | +$25.7M | 0.03% | 572 |
|
|
2019
Q2 | $76.5M | Sell |
1,430,110
-220,980
| -13% | -$11.5M | 0.02% | 654 |
|
|
2019
Q1 | $87.1M | Buy |
1,651,090
+193,153
| +13% | +$10.1M | 0.02% | 588 |
|
|
2018
Q4 | $68.5M | Sell |
1,457,937
-129,261
| -8% | -$6.74M | 0.02% | 669 |
|
|
2018
Q3 | $91.6M | Sell |
1,587,198
-12,700
| -0.8% | -$703K | 0.02% | 638 |
|
|
2018
Q2 | $87M | Buy |
1,599,898
+45,417
| +3% | +$2.25M | 0.02% | 640 |
|
|
2018
Q1 | $73.5M | Buy |
+1,554,481
| New | +$77.9M | 0.02% | 719 |
|
Other funds holding NTR
Morgan Stanley's NTR Position: Q2 2026 in Review
Morgan Stanley increased its Nutrien (NTR) stake by 6.5% in Q2 2026, buying an estimated $16.7M and bringing the position to 3,918,943 shares worth $247M. The position accounts for 0.01% of the portfolio, ranked #893.
Morgan Stanley first reported a position in NTR in Q1 2018 and has held it in 34 quarters since. The position peaked at $281M in Q2 2022. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.
- Morgan Stanley held 3,918,943 shares of Nutrien worth $247M as of Q2 2026.
- Morgan Stanley bought 238,410 Nutrien shares in Q2 2026, an estimated $16.7M.
- Nutrien made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #893 holding.
- Morgan Stanley first reported a position in Nutrien in Q1 2018 and has held it in 34 quarters since.
- Morgan Stanley's Nutrien position peaked at $281M in Q2 2022.
- 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.